Monophosphoryl lipid A adjuvant reverses a principal histologic parameter of formalin-inactivated respiratory syncytial virus vaccine-induced disease

This publication has 36 references indexed in Scilit:

• Influence of administration dose and route on the immunogenicity and protective efficacy of BBG2Na, a recombinant respiratory syncytial virus subunit vaccine candidate
  Vaccine, 2000
• Adjuvants influence the quantitative and qualitative immune response in BALBc mice immunized with respiratory syncytial virus FG subunit vaccine
  Vaccine, 1997
• Treatment of Parainfluenza Virus Type 3 Bronchiolitis and Pneumonia in a Cotton Rat Model Using Topical Antibody and Glucocorticosteroid
  The Journal of Infectious Diseases, 1996
• Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis
  The Pediatric Infectious Disease Journal, 1996
• Adjuvants for human vaccines—current status, problems and future prospects
  Vaccine, 1995
• A Prototype Recombinant Vaccine Against Respiratory Syncytial Virus and Parainfluenza Virus Type 3
  Nature Biotechnology, 1994
• Immunogenicity and pathogenicity of a triple temperature-sensitive modified respiratory syncytial virus in adult volunteers
  Vaccine, 1993
• Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3–6 months after immunization
  Vaccine, 1990
• Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat
  Virus Research, 1985
• Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants
  The Journal of Pediatrics, 1976